|Description||venture capital firm|
Kearny Venture Partners is a venture capital firm specializing in investments in incubation, seed, early, mid, and later stage investments. The firm prefers to invest in healthcare sector with a focus on medical devices and drugs, both small molecules and biopharmaceuticals. It typically invests between $2 million and $8 million initially and between $10 million and $15 million per company. Kearny Venture Partners is based in San Francisco, California.
|Aerpio Therapeutics||8/12||Series A||$27M||6|
|Akebia Therapeutics||1/12||Series B||$4.1M||7|
|Akebia Therapeutics||4/11||Series B||$22M||7|
|NextWave Pharmaceuticals||1/11||Series C||$45M||7|